Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital.
Pinet S, Durand S, Perani A, Darnaud L, Amadjikpe F, Yon M, Darbas T, Vergnenegre A, Egenod T, Simonneau Y, Le Brun-Ly V, Pestre J, Venat L, Thuillier F, Chaunavel A, Duchesne M, Fermeaux V, Guyot A, Lacorre S, Bessette B, Lalloué F, Durand K, Deluche E. Pinet S, et al. Among authors: venat l. Front Oncol. 2023 Feb 27;13:1104659. doi: 10.3389/fonc.2023.1104659. eCollection 2023. Front Oncol. 2023. PMID: 36923436 Free PMC article.
Value of microsatellite instability typing in detecting hereditary non-polyposis colorectal cancer. A prospective multicentric study by the Association Aquitaine Gastro.
Bécouarn Y, Rullier A, Gorry P, Smith D, Richard-Molard B, Echinard E, Texereau P, Beyssac R, Legoux JL, Lamouliatte H, Frebourg T, Olschwang S, Gilbert B, Venat L, Picot V, Paraf F, Longy M. Bécouarn Y, et al. Among authors: venat l. Gastroenterol Clin Biol. 2005 Jun-Jul;29(6-7):667-75. doi: 10.1016/s0399-8320(05)82155-4. Gastroenterol Clin Biol. 2005. PMID: 16142001 Free article. Clinical Trial.
The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma.
Lesueur F, de Lichy M, Barrois M, Durand G, Bombled J, Avril MF, Chompret A, Boitier F, Lenoir GM; French Familial Melanoma Study Group; Bressac-de Paillerets B, Baccard M, Bachollet B, Berthet P, Bonadona V, Bonnetblanc JM, Caron O, Chevrant-Breton J, Cuny JF, Dalle S, Delaunay M, Demange L, De Quatrebarbes J, Doré JF, Frénay M, Fricker JP, Gauthier-Villars M, Gesta P, Giraud S, Gorry P, Grange F, Green A, Huiart L, Janin N, Joly P, Kérob D, Lasset C, Leroux D, Limacher JM, Longy M, Mansard S, Marrou K, Martin-Denavit T, Mateus C, Maubec E, Olivier-Faivre L, Orlandini V, Pujol P, Sassolas B, Stoppa-Lyonnet D, Thomas L, Vabres P, Venat L, Wierzbicka E, Zattara H. Lesueur F, et al. Among authors: venat l. Br J Cancer. 2008 Jul 22;99(2):364-70. doi: 10.1038/sj.bjc.6604470. Epub 2008 Jul 8. Br J Cancer. 2008. PMID: 18612309 Free PMC article.
Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme).
Deluche E, Darbas T, Bourcier K, Montangon L, Bayard G, Caille E, Querrioux J, Suchaud C, Zabaleta S, Chaput S, Le Brun-Ly V, Pestre J, Venat L, Thuillier F, Nevado E, Maillan G, Jost J, Leobon S, Tubiana-Mathieu N, Lavau-Denes S. Deluche E, et al. Among authors: venat l. Med Oncol. 2020 Jul 25;37(8):69. doi: 10.1007/s12032-020-01393-7. Med Oncol. 2020. PMID: 32712771 Free PMC article.
Home-Based Physical Activity in Patients With Breast Cancer: During and/or After Chemotherapy? Impact on Cardiorespiratory Fitness. A 3-Arm Randomized Controlled Trial (APAC).
Vincent F, Deluche E, Bonis J, Leobon S, Antonini MT, Laval C, Favard F, Dobbels E, Lavau-Denes S, Labrunie A, Thuillier F, Venat L, Tubiana-Mathieu N. Vincent F, et al. Among authors: venat l. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420969818. doi: 10.1177/1534735420969818. Integr Cancer Ther. 2020. PMID: 33228382 Free PMC article. Clinical Trial.
Prognostic value of circulating tumor DNA at diagnosis and its early decrease after one cycle of neoadjuvant chemotherapy for patients with advanced epithelial ovarian cancer. An ancillary analysis of the CHIVA phase II GINECO trial.
Azaïs H, Brochard C, Taly V, Benoit L, Ferron G, Ray-Coquard I, You B, Abadie-Lacourtoisie S, Lebreton C, Venat L, Louvet C, Favier L, Blonz C, Dohollou N, Malaurie E, Dubot C, Kurtz JE, Pujade-Lauraine E, Rouleau E, Leary A, Bats AS, Blons H, Laurent-Puig P. Azaïs H, et al. Among authors: venat l. Gynecol Oncol. 2024 Dec 12;192:145-154. doi: 10.1016/j.ygyno.2024.12.004. Online ahead of print. Gynecol Oncol. 2024. PMID: 39671779 Free article.
23 results